Therapeutic effect of gene-therapy in combination with local X-irradiation in a mouse malignant melanoma model

Biochemical and Biophysical Research Communications

Volumn 330, Issue 3, 2005, Pages 975-981

  Jin, Guang Hui ^a   Jin, Shun Zi ^a   Liu, Yang ^a   Xu, Rui Ming ^a   Yang, Jian Zheng ^a   Pan, Xue Na ^a   Liu, Shu Zheng ^a  

^a JILIN UNIVERSITY   (China)

Author keywords

Anticancer mechanism; B7.1; Egr 1 promoter; Gene therapy; Interleukin 18; Radiotherapy

Indexed keywords

B7 ANTIGEN; EARLY GROWTH RESPONSE FACTOR 1; INTERLEUKIN 18;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL SURFACE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GENE CONSTRUCT; GENE THERAPY; IMMUNOGENICITY; IMMUNOLOGY; IMMUNOSTIMULATION; IN VITRO STUDY; MELANOMA; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT OUTCOME; TUMOR GROWTH; UPREGULATION; X IRRADIATION;

EID: 16244379224     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.03.070     Document Type: Article

References (34)

1. W.H. McBride, C.S. Chiang, J.L. Olson, C.C. Wang, J.H. Hong, F. Pajonk, G.J. Dougherty, K.S. Iwamoto, M. Pervan, and Y.P. Liao A sense of danger from radiation Radiat. Res. 162 2004 1 19
2. K. Borgmann, B. Roper, R. El-Awady, S. Brackrock, M. Bigalke, T. Dork, W. Alberti, E. Dikomey, and J. Dahm-Daphi Indicators of late normal tissue response after radiotherapy for head and neck cancer: fibroblasts, lymphocytes, genetics, DNA repair, and chromosome aberrations Radiother. Oncol. 64 2002 141 152
3. D.S. Gridley, and J.M. Slater Combining gene therapy and radiation against cancer Curr. Gene Ther. 4 2004 231 248
4. M.T. Vlachaki, M. Chhikara, L. Aguilar, X. Zhu, K.J. Chiu, S. Woo, B.S. Teh, T.C. Thompson, E.B. Butler, and E. Aguilar-Cordova Enhanced therapeutic effect of multiple injections of HSV-TK + GCV gene therapy in combination with ionizing radiation in a mouse mammary tumor model Int. J. Radiat. Oncol. Biol. Phys. 51 2001 1008 1017
5. C.M. Wu, X.Y. Li, and T.H. Huang Anti-tumor effect of pEgr-IFNgamma gene-radiotherapy in B16 melanoma-bearing mice World J. Gastroenterol. 10 2004 3011 3015
6. W. Shi, C. Teschendorf, N. Muzyczka, and D.W. Siemann Gene therapy delivery of endostatin enhances the treatment efficacy of radiation Radiother. Oncol. 66 2003 1 9
7. S.J. Collis, and T.L. DeWeese Enhanced radiation response through directed molecular targeting approaches Cancer Metastasis Rev. 23 2004 277 292
8. M. Boyd, R.J. Mairs, W.N. Keith, S.C. Ross, P. Welsh, G. Akabani, J. Owens, G. Vaidyanathan, R. Carruthers, J. Dorrens, and M.R. Zalutsky An efficient targeted radiotherapy/gene therapy strategy utilising human telomerase promoters and radiostatin and harnessing radiation-mediated bystander effects J. Gene Med. 6 2004 937 947
9. D. Kufe, and R.R. Weichselbaum Radiation therapy: activation for gene transcription and the development of genetic radiotherapy-therapeutic strategies in oncology Cancer Biol. Ther. 2 2003 326 329
10. R.R. Weichselbaum, D.W. Kufe, S.J. Advani, and B. Roizman Molecular targeting of gene therapy and radiotherapy Acta Oncol. 40 2001 735 738
11. S.P. Huang, M.S. Wu, C.T. Shun, H.P. Wang, M.T. Lin, M.L. Kuo, and J.T. Lin Interleukin-6 increases vascular endothelial growth factor and angiogenesis in gastric carcinoma J. Biomed. Sci. 11 2004 517 527
12. G..R. Thomas, Z. Chen, E. Leukinova, C. Van Waes, and J. Wen Cytokines IL-1 alpha, IL-6, and GM-CSF constitutively secreted by oral squamous carcinoma induce down-regulation of CD80 costimulatory molecule expression: restoration by interferon gamma Cancer Immunol. Immunother. 53 2004 33 40
13. H. Yamaji, T. Iizasa, E. Koh, M. Suzuki, M. Otsuji, H. Chang, S. Motohashi, S. Yokoi, K. Hiroshima, M. Tagawa, T. Nakayama, and T. Fujisawa Correlation between interleukin 6 production and tumor proliferation in non-small cell lung cancer Cancer Immunol. Immunother. 53 2004 786 792
14. C.C. Park, J.C. Morel, M.A. Amin, M.A. Connors, L.A. Harlow, and A.E. Koch Evidence of IL-18 as a novel angiogenic mediator J. Immunol. 167 2001 1644 1653
15. R. Cao, J. Farnebo, M. Kurimoto, and Y. Cao Interleukin-18 acts as an angiogenesis and tumor suppressor FASEB J. 13 1999 2195 2202
16. T. Osaki, W. Hashimoto, A. Gambotto, H. Okamura, P.D. Robbins, M. Kurimoto, M.T. Lotze, and H. Tahara Potent antitumor effects mediated by local expression of the mature form of the interferon-gamma inducing factor, interleukin-18 (IL-18) Gene Ther. 6 1999 808 815
17. T. Pentcheva-Hoang, J.G. Egen, K. Wojnoonski, and J.P. Allison B7-1 and B7-2 selectively recruit CTLA-4 and CD28 to the immunological synapse Immunity 21 2004 401 413
18. B.M. Carreno, and M. Collins The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses Annu. Rev. Immunol. 20 2002 29 53
19. M.G. Gilligan, P. Knox, S. Weedon, R. Barton, D.J. Kerr, P. Searle, and L.S. Young Adenoviral delivery of B7-1 (CD80) increases the immunogenicity of human ovarian and cervical carcinoma cells Gene Ther. 5 1998 965 974
20. G..H. Jin, M. Tian, S.Z. Jin, and S.Z. Liu Cloning and sequencing of mouse IL-18 and construction of recombinant plasmid pIRES-IL18-B7.1 J. Jilin Univ. (Med. Ed.) 29 2003 125 127
21. W.H. Liu, and Y.G. Yang Measurement of lymphokines S.L. Gong M. Zhang Practical experimental techniques in basic medicine 1991 Jilin Science and Technology Press Changchun 189 196
22. R.R. Weichselbaum, D.E. Hallahan, M.A. Beckett, H.J. Mauceri, H. Lee, V.P. Sukhatme, and D.W. Kufe Gene therapy targeted by radiation preferentially radiosensitizes tumor cells Cancer Res. 54 1994 4266 4269
23. S.Y. Wen, X.H. Wang, L. Lin, W. Guan, and S.Q. Wang Preparation and property analysis of a hepatocyte targeting pH-sensitive liposome World J. Gastroenterol. 10 2004 244 249
24. J.K. Kim, S.H. Choi, C.O. Kim, J.S. Park, W.S. Ahn, and C.K. Kim Enhancement of polyethylene glycol (PEG)-modified cationic liposome-mediated gene deliveries: effects on serum stability and transfection efficiency J. Pharm. Pharmacol. 55 2003 453 460
25. Y. Yang, S.Z. Liu, and S.B. Fu Anti-tumor effects of pNEgr-mIL-12 recombinant plasmid induced by X-irradiation and its mechanisms Biomed. Environ. Sci. 17 2004 135 143
26. F. Shi, A.L. Rakhmilevich, C.P. Heise, K. Oshikawa, P.M. Sondel, N.S. Yang, and D.M. Mahvi Intratumoral injection of interleukin-12 plasmid DNA, either naked or in complex with cationic lipid, results in similar tumor regression in a murine model Mol. Cancer Ther. 1 2002 949 957
27. E. Marino, and J.E. Cardier Differential effect of IL-18 on endothelial cell apoptosis mediated by TNF-alpha and Fas (CD95) Cytokine 22 2003 142 148
28. S. Hikosaka, I. Hara, H. Miyake, S. Hara, and S. Kamidono Antitumor effect of simultaneous transfer of interleukin-12 and interleukin-18 genes and its mechanism in a mouse bladder cancer model Int. J. Urol. 11 2004 647 652
29. J.M. Wigginton, J.K. Lee, T.A. Wiltrout, W.G. Alvord, J.A. Hixon, J. Subleski, T.C. Back, and R.H. Wiltrout Synergistic engagement of an ineffective endogenous anti-tumor immune response and induction of IFN-gamma and Fas-ligand-dependent tumor eradication by combined administration of IL-18 and IL-2 J. Immunol. 169 2002 4467 4474
30. D. Xia, F. Li, and J. Xiang Engineered fusion hybrid vaccine of IL-18 gene-modified tumor cells and dendritic cells induces enhanced antitumor immunity Cancer Biother. Radiopharm. 19 2004 322 330
31. S.Z. Liu On radiation hormesis expressed in the immune system Crit. Rev. Toxicol. 33 2003 431 441
32. Y. Yang, S.Z. Liu, and S.B. Fu Construction of pNEgr-mIL-12 recombinant plasmid and its expression in COS-7 and B16 melanoma cells J. Jilin Univ. (Med. Ed.) 28 2002 17 20
33. S. Ning, D. Laird, J.M. Cherrington, and S.J. Knox The antiangiogenic agents SU5416 and SU6668 increase the antitumor effects of fractionated irradiation Radiat. Res. 157 2002 45 51
34. D. Zips, M. Krause, F. Hessel, J. Westphal, K. Bruchner, W. Eicheler, A. Dorfler, R. Grenman, C. Petersen, M. Haberey, and M. Baumann Experimental study on different combination schedules of VEGF-receptor inhibitor PTK787/ZK222584 and fractionated irradiation Anticancer Res. 23 2003 3869 3876